Aposcience AG
1 clinical trials · Sponsor
| Record | Firm | Date |
|---|---|---|
| A Study to Evaluate Safety and Efficacy of APO-2 at Three Different Doses in Patients With Diabetic Foot Ulcer (NCT04277598) | Aposcience AG | 2020-10-09 |
Track Aposcience AG automatically
Every clearance here is in the API, with alerts when new ones post.